Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-035309
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:45
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20240930_10q.htm   iXBRL 10-Q 1317959
2 EXHIBIT 31.1 ex_718891.htm EX-31.1 12835
3 EXHIBIT 31.2 ex_718892.htm EX-31.2 12812
4 EXHIBIT 32.1 ex_718893.htm EX-32.1 4908
5 EXHIBIT 32.2 ex_718894.htm EX-32.2 4876
  Complete submission text file 0001437749-24-035309.txt   6149217

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240930.xsd EX-101.SCH 56726
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20240930_cal.xml EX-101.CAL 25222
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240930_def.xml EX-101.DEF 368990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240930_lab.xml EX-101.LAB 337805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240930_pre.xml EX-101.PRE 392855
60 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240930_10q_htm.xml XML 983675
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 241462541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)